Targeting Mcl-1 inhibits survival and self-renewal of hepatocellular cancer stem-like cells.

Clin Res Hepatol Gastroenterol

Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, PR China; Open and Key Laboratory of Hepatobiliary and Pancreatic Surgery and Digestive Organ Transplantation at Henan Universities, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, PR China; Zhengzhou Key Laboratory of Hepatobiliary and Pancreatic Diseases and Organ Transplantation, Zhengzhou, Henan, PR China; Henan Key Laboratory of Digestive Organ Transplantation, Zhengzhou, Henan, PR China. Electronic address:

Published: June 2019

Myeloid cell leukemia-1 (Mcl-1) is highly expressed in tumor tissues and cells of hepatocellular carcinoma (HCC), yet the role of Mcl-1 in cancer stem-like cells (CSLCs) remains largely unclear. Herein, we showed that knockdown of Mcl-1 significantly inhibited HCC cells to form spheres under ultra-low attachment condition in serum-free medium, and also attenuated clone formation. Inhibition of Mcl-1 by specific inhibitors S63845 or A-1210477 hindered secondary sphere formation, triggered apoptosis signaling and reduced the level of stem cell transcription factor Nanog, Sox2 and KLF4 in HCC spheroids cells. This study suggests that Mcl-1 is an essential factor for the survival and self-renewal of HCC CSLCs.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinre.2018.11.004DOI Listing

Publication Analysis

Top Keywords

survival self-renewal
8
cancer stem-like
8
stem-like cells
8
cells
5
mcl-1
5
targeting mcl-1
4
mcl-1 inhibits
4
inhibits survival
4
self-renewal hepatocellular
4
hepatocellular cancer
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!